Resources that support BBCIC’s effort to engage data consortium, managed care specialty drug experts, researchers, and industry to monitor biosimilars.
Nexus 2020 Virtual provides focused, essential learning opportunities starting with a preconference Monday, October 19, followed by a week of programming through Friday, October 23.
Current research: Oncology data fitness and descriptive analysis. The consortium will evaluate the current data capabilities of the BBCIC distributed research networks and identify additional data sources to enrich BBCIC capabilities in measures relevant to oncology outcome.
Press Release: Alexandria, Va., Jan. 25, 2017 — The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce the addition of a new participating organization, Apobiologix.
